Back to Search
Start Over
Idecabtagene Vicleucel (ide-cel, bb2121) in Relapsed and Refractory Multiple Myeloma (RRMM): Analyses of High-Risk Subgroups in the KarMMa Study
- Source :
- Transplantation and Cellular Therapy. 27:S66-S67
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
Details
- ISSN :
- 26666367
- Volume :
- 27
- Database :
- OpenAIRE
- Journal :
- Transplantation and Cellular Therapy
- Accession number :
- edsair.doi...........e10e30b3fad54f81f801e28a2770b7c8
- Full Text :
- https://doi.org/10.1016/s2666-6367(21)00094-4